The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 182, Issue , 2014, Pages 71-75

  Baijnath, Sooraj ^a   Soobryan, Nerolen ^a   Mackraj, Irene ^a   Gathiram, Prem ^a   Moodley, Jagidesa ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Animal model; L NAME; PE

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN; SILDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONAMIDE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; ENZYME INHIBITION; FEMALE; FETUS; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; REMISSION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; BIRTH; BLOOD PRESSURE; CHEMICALLY INDUCED; DISEASE MODEL; FETUS WEIGHT; LITTER SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; SPRAGUE DAWLEY RAT; TIME; URINE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; LITTER SIZE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PARTURITION; PIPERAZINES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TIME FACTORS; URINE; VASODILATOR AGENTS;

EID: 84920658224     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.08.021     Document Type: Article

References (20)

1. J.M. Roberts, and C.A. Hubel The two stage model of preeclampsia: variations on the theme Placenta 30 2009 S32 S37
2. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, and M.K. McLaughlin Preeclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 1989 1200 1204
3. N. Shanks, R. Greek, and J. Greek Are animal models predictive for humans? Philos Ethics Humanit Med 15 2009 4:2
4. E. Podjarny, G. Losonczy, and C. Baylis Animal models of preeclampsia Semin Nephrol 24 6 2004 596 606
5. M.J. Soares, D. Chakraborty, M.A. Karim Rumi, T. Konno, and S.J. Renaud Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface Placenta 33 2012 233 243
6. F.P. McCarthy, J.C. Kingdom, L.C. Kenny, and S.K. Walsh Animal models of preeclampsia; uses and limitations Placenta 32 2011 413 419
7. S.A. Karamunchi, and I.E. Stillman In vivo rat model of preeclampsia Methods Mol Med 122 2006 393 399
8. S.V. Ramesar, I. Mackraj, P. Gathiram, and J. Moodley Sildenafil citrate decreases sFlt and sEng in pregnant l-NAME treated, Sprague Dawley rats Eur J Obstet Gynecol 157 2 2011 136 140
9. S.V. Ramesar, I. Mackraj, P. Gathiram, and J. Moodley Sildenafil citrate improves fetal outcomes in pregnant l-NAME treated Sprague-Dawley rats Eur J Obstet Gynecol Reprod Biol 149 1 2010 22 26
10. D.O. Bates An unexpected tail of VEGF and PlGF in PE Biochem Soc Trans 39 6 2011 1576 1582
11. R. Zatz, and C. Baylis Chronic nitric oxide inhibition model six years on Hypertension 32 1998 958 964
12. Amiri Iraj, Sobhani Aligholi, Abolhassani Farid, Omidinia Eskandar, Akbari Mohammad, and Farimani Marzieh The effect of nitric oxide on mouse pre-implantation embryo development and apoptosis Iran Biomed J 7 July (3) 2003 107 111
13. K. Wang, S. Ahmad, and M. Cai Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia Circulation 127 2013 2514 2522
14. M. Boolell, S. Gepi-Attee, J.C. Gingell, and M.J. Allen Sildenafil a novel effective oral therapy for male erectile dysfunction B J Urol 78 1996 257 261
15. W.D. Zoma, R.s Baker, A. Friedman, and K.E. Clark SC (Viagra) increases uterine blood flow and potentiates estrogen-induced vasodilation J Soc Gynecol Invest 1 2001 286A
16. D. Raymond, and E. Peterson A critical review of early-onset and late-onset preeclampsia Obstet Gynecol Surv 66 8 2011 497 506
17. A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. D'Anna Endoglin, PlGF and sFlt-1 as markers for predicting PE Acta Obstet Gynecol Scand 87 2008 837 842
18. Y. Chen Novel angiogenic factors for predicting preeclampsia: sFlt-1, PlGF, and soluble endoglin Open Clin Chem J 2 2009 1 6
19. D.E. Henao, A.P. Cadavid, and M.A. Saleem Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women J Obstet Gynaecol Res 39 1 2013 46 52
20. D.E. Henao, and M.A. Saleem Proteinuria in preeclampsia from a podocyte injury perspective Curr Hypertens Rep 15 6 2013 600 605